Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients
The severe outbreak of SARS-CoV-2, the etiological agent of COVID-19, has precipitated the development of vaccines and antiviral therapeutics. However, it remains a significant public health concern. This study investigated the association between disease severity, biomarkers of coagulation, and end...
Saved in:
Main Authors: | Panagiota Tsiatsiou, Dimitrios Pilalas, Vasiliki Tsaireli, Antonia Lanta, Georgios Meletis, Angeliki Kassomenaki, Evangelia Tza, Lampros Tampakas, Helen Gkeka, Maria Papaioannou, Efthymia Protonotariou, Lemonia Skoura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/47/6/409 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating Elevated E-Selectin and P-Selectin Levels in Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patients: The Stepping Stone to a Future Clinical Approach
by: Syntia Nusanti, et al.
Published: (2025-01-01) -
Thrombocytopenia and endothelial dysfunction in hemorrhagic fever with renal syndrome
by: G. A. Mukhetdinova, et al.
Published: (2018-12-01) -
Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01) -
High Levels of Soluble P-selectin, Neutrophil Extracellular Traps, and Myeloperoxidase as Risk Factor of Deep Vein Thrombosis in Malignancy Patients Receiving Platinum-Based Chemotherapy [version 2; peer review: 2 approved, 1 approved with reservations]
by: Ketut Suega, et al.
Published: (2025-07-01) -
Prognostic value of P-selectin and sST2 in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-11-01)